If you are currently taking semaglutide (Wegovy, Ozempic or Rybelsus) and notice sudden loss of vision or other vision changes, you should seek urgent medical assistance and urgently attend eye casualty or A&E
Key benefits for perimenopausal women: Targets visceral and subcutaneous fat accumulation that tends to increase as estrogen declines and metabolism slows Does not affect blood sugar or cause stimulant-related side effects such as anxiety or elevated heart rate Supports fat loss while preserving lean muscle tissue, important for maintaining metabolic rate during hormonal transition Administration method: Subcutaneous injection into abdominal fatty tissue, typically 2 inches from the navel
You're welcome to bring a family member or caregiver along
Do not take another dose on your originally scheduled day
Powered by Froala Editor Drug Interactions Ozempic (semaglutide) may interact with other drugs, altering effectiveness or increasing side effects
One recent study found that GLP-1RAs may help lower the risk for depression compared to another medication for diabetes treatment, dipeptidyl peptidase-4 inhibitors